Recent warm weather and rain may be giving mosquitoes an early start in Santa Barbara County. Brian Cabrera, general manager of the Mosquito and Vector ...

The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...

Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.

Since doctors first identified Lassa fever in 1969, when four missionary nurses died from the viral haemorrhagic illness in the town of Lassa in Borno State, outbreaks have taken place frequently, ...

BioAnalysis launches BASIS 2.0, its next-gen GMP-compliant AUC software for gene therapy. Higher throughput, one-click ...

Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs).

OXB announces date for Capital Markets Day and participation in upcoming investor conferencesOxford, UK – 3 March 2026: OXB (LSE: OXB), a global ...

A 14-year journey from “unexplained headaches” to confirmed HSV-2 meningitis, highlighting how accurate diagnosis, antiviral ...

Understanding the clinical overlap between vector-borne infections and pediatric acute-onset neuropsychiatric syndromes—and a ...

Deepfakes and injection attacks are targeting identity verification moments, from onboarding to account recovery. Incode explains why enterprises must validate the full session—media, device integrity ...

Virus-based products are at a curious stage of the journey to improve public health. Distrust of vaccines continues to climb amid the specters of COVID and current upheaval of traditional ...